Abstract
Competing endogenous RNAs (ceRNAs) are RNA transcripts that can crosstalk with each other by competing for shared microRNAs (miRNAs) through miRNA response elements (MREs). Involved in ceRNA networks, the RNA transcripts may be in a balance, disruption of which could lead to tumorigenesis. Here we reveal a ceRNA interaction between PIK3C2A and CD151 mRNAs in hepatocellular carcinoma (HCC) cells. PIK3C2A is a candidate ceRNA of CD151 because mRNA 3′ untranslated regions (3′UTRs) of these two genes contain miR-124 binding sites. miR-124 is downregulated, while PIK3C2A and CD151 are upregulated in HCC cells compared with normal hepatocytes. Direct and negative regulation of PIK3C2A and CD151 by miR-124 was confirmed in HCC cells. miR-124 and the two potential ceRNAs are all recruited to the RNA-induced silencing complex (RISC). In HCC cell lines QGY- 7703 and SMMC-7721, and normal hepatic cell line HL-7702, miR-124 plays a tumor suppressor role by targeting PIK3C2A and CD151. The MREs within PIK3C2A 3′UTR can independently stimulate CD151 expression level by acting as miR-124 decoys. PIK3C2A MREs enhance HCC cell malignancy by absorbing endogenous miR-124 and activating CD151 in HCC cells. We conclude that PIK3C2A 3′UTR functions as a trans activator to stimulate CD151 by competing for miR-124 binding in HCC cells. The collaboration of PIK3C2A and CD151 through ceRNA mechanism may be implicated in HCC initiation and development.
Highlights
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide with over 500,000 new cases being diagnosed each year [1, 2]
Long non-coding RNAs act as Competing endogenous RNAs (ceRNAs) to facilitate protein-coding genes [20, 21]. miRNA-mediated gene regulation has been validated in hepatocellular carcinoma (HCC) cells [22, 23], and several studies have confirmed the ceRNA mechanism in HCC cells [24, 25]
CD151, its potential ceRNA PIK3C2A and their possible regulator miR-124 are all dysregulated in HCC cells
Summary
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer deaths worldwide with over 500,000 new cases being diagnosed each year [1, 2]. A single miRNA can regulate thousands of target transcripts, and several miRNAs can corporately bind to separate MREs within www.impactjournals.com/oncotarget a single RNA transcript [6,7,8]. Regulation of gene expression through competition for miRNA binding is a general phenomenon [9, 10], and perturbations of ceRNA networks may have profound implications for cancer [13,14,15]. The tumor suppressor PTEN has been most extensively validated as competing with a variety of ceRNAs in different cancers. MiRNA-mediated gene regulation has been validated in HCC cells [22, 23], and several studies have confirmed the ceRNA mechanism in HCC cells [24, 25]. The ceRNA mechanism in HCC is still largely unknown
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.